+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

miRNA Tools and Services Market Size, Share & Industry Trends Analysis Report by Technology (qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools), End-user, Product & Services, Regional Outlook and Forecast, 2022-2028

  • PDF Icon

    Report

  • 218 Pages
  • October 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694659
The Global miRNA Tools and Services Market size is expected to reach $939.8 million by 2028, rising at a market growth of 17.8% CAGR during the forecast period.

miRNA is a non-coding and small gene that is known to influence the expression of certain other genes. miRNAs or microRNAs control apoptosis, inflammation, immunological response, and development and differentiation. A miRNA tool kit provides researchers with practical tools to use when examining these phenomena at their most primitive level, enabling them to more quickly grasp how it functions than by trying to develop a custom test from the beginning.



The increase in cardiovascular disease and cancer incidences globally has boosted the usage of miRNA as a tool in screening and diagnosis processes. Additionally, the application of miRNA is expected to rise due to the usage of technological and bioinformatics-improved systems (such as NGS).

MicroRNAs, which are made up of 18-25 nucleotides, function as post-transcriptional negative regulators of gene expression. Through translational repression or the destruction of target mRNAs, miRNAs regulate the post-transcriptional regulation of genes. MiRNAs regulate a variety of biological activities including cell differentiation, development, proliferation, and death by altering the availability of mRNAs and protein synthesis.

Variations in miRNA-based expression profiles have been seen in a number of disorders, including cancer, osteoporosis, cardiac disease, and heart failure. These changes are linked to dysfunctional cellular processes. Numerous miRNAs affect tumor and oncogenes suppressor genes that are directly involved in the development of cancer.

COVID-19 Impact Analysis

The pandemic had a detrimental effect on the expansion of the market for miRNA equipment and services since production was slowed down by global lockdowns and social distance rules. The pandemic propelled research and technological investments in the medical tools sector to develop rapid testing kits. As a result, simultaneous efforts were also made in the utilization of miRNAs. As research demonstrates that cc-miRNAs can be utilized as a therapy for the COVID-19 pandemic, the industry is expanded along with the rise in infectious viruses.

Market Growth Factors

Rising technological advancements in the utilization of miRNA

In recent years, technological advancements in the crucial stages of miRNA expression profiling, validation, and target gene identification have provided manufacturers and researchers with the motivation to provide novel solutions. For application in preclinical functional research and translational medicine, HTG Molecular Diagnostics Inc., for example, introduced a complete panel for miRNA expression analysis called the HTG EdgeSeq mouse miRNA whole transcriptome test. Due to their crucial roles in numerous biological processes, such as development, differentiation, cell proliferation, and death, miRNA expression profiling is of great interest.

Increasing number of clinical trials for chronic illnesses

MiRNA's pre-clinical and clinical research applications are being expanded by ongoing investigations and clinical trials. A growing number of studies point to the significant use of miRNAs as medications for medical therapy in practically all human health disorders, biomarkers for pathogenic diseases, or modulators of treatment resistance. As a result, one of the important reasons driving the growth of the miRNA is the expansion of clinical trials to assess the effectiveness of miRNA in the therapy of various chronic illnesses.

Market Restraining Factors

Inefficacy of miRNA in delivering results to the target

Similar to small interfering RNA medicines, microRNA-based therapies face difficulties with delivery, the possibility of off-target effects, and safety. The tissue-specific delivery of miRNA therapies is one of the main challenges. One miRNA's ability to target several genes is potentially a disadvantage because potential off-target effects could result in harmful outcomes. Another important consideration in the creation of miRNA therapies is the possibility that some biological activities of miRNAs could be partially redundant or cell-type dependent.

Technology Outlook

On the basis of technology, the miRNA tools and services market is divided into extraction tools, qRT-PCR, NGS, microarray, functional analysis tools, and others. The qRT-PCR segment acquired the largest revenue share in the miRNA tools and services market in 2021. The rise in cancer cases, the occurrence of chronic diseases, increased financing for research into gene therapy, and cutting-edge drug development techniques that employ RNAi-based methods are all factors that have contributed to the segment's expansion.



End-user Outlook

Based on end user, the miRNA tools and services market is categorized into research and academic institutes, IVD, pharma and biotech companies, and CROs. The IVD, pharma and biotech companies segment witnessed a significant revenue share in the miRNA tools and services market in 2021. Pharma and biotech businesses employ miRNA Tools & Services to test the safety of medications during clinical trials or as part of the drug discovery process. Additionally, they use them when creating diagnostics for both scientific (such as detecting gene expression patterns linked to specific tumors) and commercial (such as prenatal testing) objectives.

Product & Services Outlook

Based on product and services, the miRNA tools and services market is bifurcated into research tools and services. The research tools segment garnered the highest revenue share in the miRNA tools and services market in 2021. The rising prevalence of chronic diseases like cardiovascular and cancer disorders, research funding from various companies, and recent developments like the use of bioinformatics for research have all contributed to the segment's growth. The kits, reagents, and other consumables categories are found under this segment.

Regional Outlook

On the basis of region, the miRNA tools and services market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the highest revenue share in the miRNA tools and services market in 2021. Growth in the segment can be ascribed to a number of things, including the existence of important players, considerable R&D efforts, and developed infrastructure for genomics, proteomics, and oncology research. Companies in the area are also getting their miRNA biomarkers approved for patents.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include General Electric (GE) Co., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., New England BioLabs, Inc., Promega Corporation, GeneCopoeia and Norgen Biotek Corp.

Scope of the Study

By Technology

  • qRT-PCR
  • Extraction Tools
  • NGS
  • Microarray
  • Functional Analysis Tools
  • Others

By End-user

  • Research & Academic Institutes
  • IVD, Pharma & Biotech Companies
  • CROs

By Product & Services

  • Research Tools
  • Services

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • General Electric (GE) Co.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • New England BioLabs, Inc.
  • Promega Corporation
  • GeneCopoeia
  • Norgen Biotek Corp.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global miRNA Tools and Services Market, by Technology
1.4.2 Global miRNA Tools and Services Market, by End-user
1.4.3 Global miRNA Tools and Services Market, by Product & Services
1.4.4 Global miRNA Tools and Services Market, by Geography
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global miRNA Tools and Services Market by Technology
3.1 Global qRT-PCR Market by Region
3.2 Global Extraction Tools Market by Region
3.3 Global NGS Market by Region
3.4 Global Microarray Market by Region
3.5 Global Functional Analysis Tools Market by Region
3.6 Global Others Market by Region
Chapter 4. Global miRNA Tools and Services Market by End-user
4.1 Global Research & Academic Institutes Market by Region
4.2 Global IVD, Pharma & Biotech Companies Market by Region
4.3 Global CROs Market by Region
Chapter 5. Global miRNA Tools and Services Market by Product & Services
5.1 Global Research Tools Market by Region
5.2 Global Services Market by Region
Chapter 6. Global miRNA Tools and Services Market by Region
6.1 North America miRNA Tools and Services Market
6.1.1 North America miRNA Tools and Services Market by Technology
6.1.1.1 North America qRT-PCR Market by Country
6.1.1.2 North America Extraction Tools Market by Country
6.1.1.3 North America NGS Market by Country
6.1.1.4 North America Microarray Market by Country
6.1.1.5 North America Functional Analysis Tools Market by Country
6.1.1.6 North America Others Market by Country
6.1.2 North America miRNA Tools and Services Market by End-user
6.1.2.1 North America Research & Academic Institutes Market by Country
6.1.2.2 North America IVD, Pharma & Biotech Companies Market by Country
6.1.2.3 North America CROs Market by Country
6.1.3 North America miRNA Tools and Services Market by Product & Services
6.1.3.1 North America Research Tools Market by Country
6.1.3.2 North America Services Market by Country
6.1.4 North America miRNA Tools and Services Market by Country
6.1.4.1 US miRNA Tools and Services Market
6.1.4.1.1 US miRNA Tools and Services Market by Technology
6.1.4.1.2 US miRNA Tools and Services Market by End-user
6.1.4.1.3 US miRNA Tools and Services Market by Product & Services
6.1.4.2 Canada miRNA Tools and Services Market
6.1.4.2.1 Canada miRNA Tools and Services Market by Technology
6.1.4.2.2 Canada miRNA Tools and Services Market by End-user
6.1.4.2.3 Canada miRNA Tools and Services Market by Product & Services
6.1.4.3 Mexico miRNA Tools and Services Market
6.1.4.3.1 Mexico miRNA Tools and Services Market by Technology
6.1.4.3.2 Mexico miRNA Tools and Services Market by End-user
6.1.4.3.3 Mexico miRNA Tools and Services Market by Product & Services
6.1.4.4 Rest of North America miRNA Tools and Services Market
6.1.4.4.1 Rest of North America miRNA Tools and Services Market by Technology
6.1.4.4.2 Rest of North America miRNA Tools and Services Market by End-user
6.1.4.4.3 Rest of North America miRNA Tools and Services Market by Product & Services
6.2 Europe miRNA Tools and Services Market
6.2.1 Europe miRNA Tools and Services Market by Technology
6.2.1.1 Europe qRT-PCR Market by Country
6.2.1.2 Europe Extraction Tools Market by Country
6.2.1.3 Europe NGS Market by Country
6.2.1.4 Europe Microarray Market by Country
6.2.1.5 Europe Functional Analysis Tools Market by Country
6.2.1.6 Europe Others Market by Country
6.2.2 Europe miRNA Tools and Services Market by End-user
6.2.2.1 Europe Research & Academic Institutes Market by Country
6.2.2.2 Europe IVD, Pharma & Biotech Companies Market by Country
6.2.2.3 Europe CROs Market by Country
6.2.3 Europe miRNA Tools and Services Market by Product & Services
6.2.3.1 Europe Research Tools Market by Country
6.2.3.2 Europe Services Market by Country
6.2.4 Europe miRNA Tools and Services Market by Country
6.2.4.1 Germany miRNA Tools and Services Market
6.2.4.1.1 Germany miRNA Tools and Services Market by Technology
6.2.4.1.2 Germany miRNA Tools and Services Market by End-user
6.2.4.1.3 Germany miRNA Tools and Services Market by Product & Services
6.2.4.2 UK miRNA Tools and Services Market
6.2.4.2.1 UK miRNA Tools and Services Market by Technology
6.2.4.2.2 UK miRNA Tools and Services Market by End-user
6.2.4.2.3 UK miRNA Tools and Services Market by Product & Services
6.2.4.3 France miRNA Tools and Services Market
6.2.4.3.1 France miRNA Tools and Services Market by Technology
6.2.4.3.2 France miRNA Tools and Services Market by End-user
6.2.4.3.3 France miRNA Tools and Services Market by Product & Services
6.2.4.4 Russia miRNA Tools and Services Market
6.2.4.4.1 Russia miRNA Tools and Services Market by Technology
6.2.4.4.2 Russia miRNA Tools and Services Market by End-user
6.2.4.4.3 Russia miRNA Tools and Services Market by Product & Services
6.2.4.5 Spain miRNA Tools and Services Market
6.2.4.5.1 Spain miRNA Tools and Services Market by Technology
6.2.4.5.2 Spain miRNA Tools and Services Market by End-user
6.2.4.5.3 Spain miRNA Tools and Services Market by Product & Services
6.2.4.6 Italy miRNA Tools and Services Market
6.2.4.6.1 Italy miRNA Tools and Services Market by Technology
6.2.4.6.2 Italy miRNA Tools and Services Market by End-user
6.2.4.6.3 Italy miRNA Tools and Services Market by Product & Services
6.2.4.7 Rest of Europe miRNA Tools and Services Market
6.2.4.7.1 Rest of Europe miRNA Tools and Services Market by Technology
6.2.4.7.2 Rest of Europe miRNA Tools and Services Market by End-user
6.2.4.7.3 Rest of Europe miRNA Tools and Services Market by Product & Services
6.3 Asia Pacific miRNA Tools and Services Market
6.3.1 Asia Pacific miRNA Tools and Services Market by Technology
6.3.1.1 Asia Pacific qRT-PCR Market by Country
6.3.1.2 Asia Pacific Extraction Tools Market by Country
6.3.1.3 Asia Pacific NGS Market by Country
6.3.1.4 Asia Pacific Microarray Market by Country
6.3.1.5 Asia Pacific Functional Analysis Tools Market by Country
6.3.1.6 Asia Pacific Others Market by Country
6.3.2 Asia Pacific miRNA Tools and Services Market by End-user
6.3.2.1 Asia Pacific Research & Academic Institutes Market by Country
6.3.2.2 Asia Pacific IVD, Pharma & Biotech Companies Market by Country
6.3.2.3 Asia Pacific CROs Market by Country
6.3.3 Asia Pacific miRNA Tools and Services Market by Product & Services
6.3.3.1 Asia Pacific Research Tools Market by Country
6.3.3.2 Asia Pacific Services Market by Country
6.3.4 Asia Pacific miRNA Tools and Services Market by Country
6.3.4.1 China miRNA Tools and Services Market
6.3.4.1.1 China miRNA Tools and Services Market by Technology
6.3.4.1.2 China miRNA Tools and Services Market by End-user
6.3.4.1.3 China miRNA Tools and Services Market by Product & Services
6.3.4.2 Japan miRNA Tools and Services Market
6.3.4.2.1 Japan miRNA Tools and Services Market by Technology
6.3.4.2.2 Japan miRNA Tools and Services Market by End-user
6.3.4.2.3 Japan miRNA Tools and Services Market by Product & Services
6.3.4.3 India miRNA Tools and Services Market
6.3.4.3.1 India miRNA Tools and Services Market by Technology
6.3.4.3.2 India miRNA Tools and Services Market by End-user
6.3.4.3.3 India miRNA Tools and Services Market by Product & Services
6.3.4.4 South Korea miRNA Tools and Services Market
6.3.4.4.1 South Korea miRNA Tools and Services Market by Technology
6.3.4.4.2 South Korea miRNA Tools and Services Market by End-user
6.3.4.4.3 South Korea miRNA Tools and Services Market by Product & Services
6.3.4.5 Singapore miRNA Tools and Services Market
6.3.4.5.1 Singapore miRNA Tools and Services Market by Technology
6.3.4.5.2 Singapore miRNA Tools and Services Market by End-user
6.3.4.5.3 Singapore miRNA Tools and Services Market by Product & Services
6.3.4.6 Malaysia miRNA Tools and Services Market
6.3.4.6.1 Malaysia miRNA Tools and Services Market by Technology
6.3.4.6.2 Malaysia miRNA Tools and Services Market by End-user
6.3.4.6.3 Malaysia miRNA Tools and Services Market by Product & Services
6.3.4.7 Rest of Asia Pacific miRNA Tools and Services Market
6.3.4.7.1 Rest of Asia Pacific miRNA Tools and Services Market by Technology
6.3.4.7.2 Rest of Asia Pacific miRNA Tools and Services Market by End-user
6.3.4.7.3 Rest of Asia Pacific miRNA Tools and Services Market by Product & Services
6.4 LAMEA miRNA Tools and Services Market
6.4.1 LAMEA miRNA Tools and Services Market by Technology
6.4.1.1 LAMEA qRT-PCR Market by Country
6.4.1.2 LAMEA Extraction Tools Market by Country
6.4.1.3 LAMEA NGS Market by Country
6.4.1.4 LAMEA Microarray Market by Country
6.4.1.5 LAMEA Functional Analysis Tools Market by Country
6.4.1.6 LAMEA Others Market by Country
6.4.2 LAMEA miRNA Tools and Services Market by End-user
6.4.2.1 LAMEA Research & Academic Institutes Market by Country
6.4.2.2 LAMEA IVD, Pharma & Biotech Companies Market by Country
6.4.2.3 LAMEA CROs Market by Country
6.4.3 LAMEA miRNA Tools and Services Market by Product & Services
6.4.3.1 LAMEA Research Tools Market by Country
6.4.3.2 LAMEA Services Market by Country
6.4.4 LAMEA miRNA Tools and Services Market by Country
6.4.4.1 Brazil miRNA Tools and Services Market
6.4.4.1.1 Brazil miRNA Tools and Services Market by Technology
6.4.4.1.2 Brazil miRNA Tools and Services Market by End-user
6.4.4.1.3 Brazil miRNA Tools and Services Market by Product & Services
6.4.4.2 Argentina miRNA Tools and Services Market
6.4.4.2.1 Argentina miRNA Tools and Services Market by Technology
6.4.4.2.2 Argentina miRNA Tools and Services Market by End-user
6.4.4.2.3 Argentina miRNA Tools and Services Market by Product & Services
6.4.4.3 UAE miRNA Tools and Services Market
6.4.4.3.1 UAE miRNA Tools and Services Market by Technology
6.4.4.3.2 UAE miRNA Tools and Services Market by End-user
6.4.4.3.3 UAE miRNA Tools and Services Market by Product & Services
6.4.4.4 Saudi Arabia miRNA Tools and Services Market
6.4.4.4.1 Saudi Arabia miRNA Tools and Services Market by Technology
6.4.4.4.2 Saudi Arabia miRNA Tools and Services Market by End-user
6.4.4.4.3 Saudi Arabia miRNA Tools and Services Market by Product & Services
6.4.4.5 South Africa miRNA Tools and Services Market
6.4.4.5.1 South Africa miRNA Tools and Services Market by Technology
6.4.4.5.2 South Africa miRNA Tools and Services Market by End-user
6.4.4.5.3 South Africa miRNA Tools and Services Market by Product & Services
6.4.4.6 Nigeria miRNA Tools and Services Market
6.4.4.6.1 Nigeria miRNA Tools and Services Market by Technology
6.4.4.6.2 Nigeria miRNA Tools and Services Market by End-user
6.4.4.6.3 Nigeria miRNA Tools and Services Market by Product & Services
6.4.4.7 Rest of LAMEA miRNA Tools and Services Market
6.4.4.7.1 Rest of LAMEA miRNA Tools and Services Market by Technology
6.4.4.7.2 Rest of LAMEA miRNA Tools and Services Market by End-user
6.4.4.7.3 Rest of LAMEA miRNA Tools and Services Market by Product & Services
Chapter 7. Company Profiles
7.1 General Electric (GE) Co.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Agilent Technologies, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent Strategies and Developments
7.2.5.1 Partnerships, Collaborations, and Agreements
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Bio-Rad laboratories, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Qiagen N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations, and Agreements
7.5.5.2 Product Launches and Product Expansions
7.5.5.3 Acquisition and Mergers
7.6 Illumina, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.7 New England BioLabs, Inc.
7.7.1 Company Overview
7.8 Promega Corporation
7.8.1 Company Overview
7.9 GeneCopoeia, Inc.
7.9.1 Company Overview
7.10. Norgen Biotek Corp.
7.10.1 Company Overview

Companies Mentioned

  • General Electric (GE) Co.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • New England BioLabs, Inc.
  • Promega Corporation
  • GeneCopoeia
  • Norgen Biotek Corp.

Methodology

Loading
LOADING...